Get started
Author

Suki Shergill

Observed names: S Shergill, S. Shergill, Shergill, Suki
Observed institution: Simon Fraser University
ORCID: 0000-0001-5319-6770
Observed ORCID: 0000-0001-5319-6770
OpenAlex ID: A5020057997
Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer
2020 · Thomas Walter, Neil S. Hawkins, et al. · Journal of Cancer Research and Clinical Oncology · 32
PDF
Patient Preferences for Advanced Hepatocellular Carcinoma Treatment: A Multicountry Stated Preference Study
2021 · Siu Hing Lo, Rohini Sharma, et al. · Future Oncology · 22
PDF
Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life
2022 · Ion Agirrezabal, Victoria K. Brennan, et al. · Advances in Therapy · 18
PDF
A cost analysis of SIR-Spheres yttrium-90 resin microspheres versus tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma in France, Italy, Spain and the UK
2020 · Richard F. Pollock, Fabien Colaone, et al. · Journal of Medical Economics · 17
Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison
2023 · Ion Agirrezabal, Mohamed Bouattour, et al. · European Journal of Cancer · 13
PDF
Cost–Utility Analysis of Selective Internal Radiation Therapy with Y-90 Resin Microspheres in Hepatocellular Carcinoma
2020 · Noemi Muszbek, Edit Remak, et al. · Future Oncology · 13
A cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK
2020 · V. K. Brennan, F. Colaone, et al. · Journal of Medical Economics · 9
A systematic literature review and network meta-analysis of first-line treatments for unresectable hepatocellular carcinoma based on data from randomized controlled trials
2020 · Richard F. Pollock, Victoria K. Brennan, et al. · Expert Review of Anticancer Therapy · 7
PDF
Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis
2024 · André L. F. Azeredo-da-Silva, Victor Hugo F. de Jesus, et al. · Advances in Therapy · 6
PDF
Advances in Delivery of Selective Internal Radiation Therapy (SIRT): Economic and Logistical Effects of Same-Stay Work-Up and Procedure in the Treatment of Unresectable Liver Tumors in England
2022 · Richard F. Pollock, Suki Shergill, et al. · Advances in Therapy · 6
PDF
Cost effectiveness of selective internal radiation therapy (SIRT) with Y-90 resin microspheres versus sorafenib in Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma patients in the UK
2017 · D. Palmer, P. Ross, et al. · Annals of Oncology · 6
Cost-effectiveness of selective internal radiation therapy with Y-90 resin microspheres for intermediate- and advanced-stage hepatocellular carcinoma in Brazil
2023 · Ion Agirrezabal, Luiz Sérgio Pereira Grillo Junior, et al. · Journal of Medical Economics · 5
PDF
Association of adverse events and quality of life in patients with unresectable hepatocellular carcinoma
2024 · Ion Agirrezabal, Richard F. Pollock, et al. · Quality of Life Research · 4
Effects of Trial Population Selection on Quality of Life and Healthcare Decision-Making: A Systematic Review and Example in the Treatment of Hepatocellular Carcinoma with Radioembolization
2021 · Richard F Pollock, Fabien Colaone, et al. · ClinicoEconomics and Outcomes Research · 3
PDF
Pcn98 Cost-comparison Analysis of Selective Internal Radiation Therapy (sirt) and Transarterial Chemoembolisation (tace) in Unresectable Hepatocellular Carcinoma (hcc)
2019 · N. Muszbek, R. Evans, et al. · Value in Health · 3
PDF
Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC)
2021 · Noemi Muszbek, Rachel Evans, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2
PDF
Pcn83 Cost-utility Analyis of Selective Internal Radiation Therapy (sirt) With Y-90 Resin Microspheres in Hepatocellular Carcinoma (hcc)
2019 · N. Muszbek, E. Remak, et al. · Value in Health · 2
PDF
Pcn40 a Systematic Review and Exploratory Network Meta-analysis of Third-line Treatments for Metastatic Colorectal Cancer
2020 · T. Walter, N.S. Hawkins, et al. · Value in Health · 1
Pcn78 Changes in Health State Costs in Hepatocellular Carcinoma (hcc)
2019 · N. Muszbek, R. Evans, et al. · Value in Health · 1
PDF
Pcn21 Treatment Comparisons in Patients With Unresectable Heptocellular Carcinoma (hcc) Who Are Ineligible for Transarterial Chemoembolisation (tace)
2019 · R. Evans, N. Hawkins, et al. · Value in Health · 1
PDF
Energy-rate equidistribution for adaptive SSAV--BDF2 integration of gradient flows
2026 · Shergill, Suki, Williams, JF · arXiv (Cornell University)
PDF
PD28 Cost-Effectiveness Of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres For Unresectable Hepatocellular Carcinoma In Brazil
2022 · Ion Agirrezabal, Victoria Brennan, et al. · International Journal of Technology Assessment in Health Care
PDF
PD32 Cost-Utility Of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres For Chemotherapy-Refractory Metastatic Colorectal Cancer In Brazil
2022 · Richard F Pollock, Suki Shergill, et al. · International Journal of Technology Assessment in Health Care
PDF
POSA134 Evaluating the Economic Effects of Flexible Radionuclide Delivery Timing and Same-Day Work-up and Radioembolization in Patients with Unresectable Liver Tumors Undergoing Selective Internal Radiation Therapy
2022 · R Pollock, V Brennan, et al. · Value in Health
P-125 Caring for more than survival: A survey of patient preferences in advanced hepatocellular carcinoma
2021 · R. Sharma, S. Lo, et al. · Annals of Oncology
PDF
Works count: 32
Citation count: 171
H-index: 7
I10-index: 6
Year
Topic
Type